(Q28235965)
Statements
Therapy with OKT3 monoclonal antibody in refractory T cell acute lymphoblastic leukemia induces interleukin-2 responsiveness (English)
0 references
March 1995
0 references
9
0 references
3
0 references
382-90
0 references